New approach to tumor therapy for inoperable areas of the brain chronic intraparenchymal drug delivery

Journal of Neuro-Oncology

Volumn 60, Issue 2, 2002, Pages 151-158

  Carson Sr , B S ^a   Wu, Q ^a   Tyler, B ^a   Sukay, L ^a   Raychaudhuri, R ^a   DiMeco, F ^b   Clatterbuck, R E ^a   Olivi, A ^a   Guarnieri, M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Brainstem tumors; Carboplatin; CNS cancer; Intracranial drug delivery; Intraparenchymal therapy

Indexed keywords

CARBOPLATIN; CARMUSTINE; DEXAMETHASONE; PLATINUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN CANCER; BRAIN STEM TUMOR; CANCER SURVIVAL; CANCER THERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CHI SQUARE TEST; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG DISTRIBUTION; DRUG INFUSION; DRUG TISSUE LEVEL; FEASIBILITY STUDY; FEMALE; INOCULATION; INOPERABLE CANCER; LETHAL DOSE; NONHUMAN; OSMOTIC PUMP; PROBABILITY; RAT; RODENT; STATISTICAL ANALYSIS; SURVIVAL RATE; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN STEM NEOPLASMS; CARBOPLATIN; DRUG DELIVERY SYSTEMS; FEMALE; GLIOMA; INFUSION PUMPS; RATS; RATS, INBRED F344; SURVIVAL ANALYSIS;

EID: 0036842689     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020626419269     Document Type: Article

References (34)

1. Burke M, Langer R, Brem H: Central nervous system, drug delivery to treat. In: Mathiowitz E (ed) The Encyclopedia of Controlled Drug Delivery. John Wiley & Sons, New York, 1999, pp 184-212
2. Haroun RI, Brem H: Local drug delivery. Curr Opin Oncol 12: 1887-1893, 2000
3. Chen W, Lu DR: Carboplatin-loaded PLGA microspheres for intracerebral injection: formulation and characterization. J Microencapsul 16: 551-563, 1999
4. Chen W, He J, Olson JJ, Lu DR: Direct intracerebral delivery of carboplatin from PLGA microspheres against experimental malignant glioma in rats. Drug Deliv 5: 101-110, 1998
5. Emerich DF, Winn SR, Hu Y, Marsh J, Snodgrass P, LaFreniere D, Wiens T, Hasler BP, Bartus RT: Injectable chemotherapeutic microspheres and glioma I: enhanced survival following implantation into the cavity wall of debulked tumors. Pharm Res 17: 767-775, 2000
6. Emerich DF, Winn SR, Snodgrass P, LaFreniere D, Agostino M, Wiens T, Xiong H, Bartus RT: Injectable chemotherapeutic microspheres and glioma II: enhanced survival following implantation into deep inoperable tumors. Pharm Res 17: 776-781, 2000
7. Ram Z, Samid D, Walbridge S, Oshiro E, Viola J, Tao-Cheng J-H, Shack S, Thibault A, Meyers C, Oldfield E: Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenyl acetate. Cancer Res 54: 2923-2927, 1994
8. Laske DW, Youle RJ, Oldfield EH: Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3: 1362-1368, 1997
9. Ikeda Y, Carson BS, Lauer JA, Long DM: Therapeutic effects of local delivery of dexamethasone on experimental brain tumors and peritumoral brain edema. J Neurosurg 79: 716-721, 1993
10. Hagihara N, Walbridge S, Olson AW, Oldfield EH, Youle RJ: Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107. Cancer Res 60: 230-234, 2000
11. Wu Q, Tyler B, Sukay L, Rhines L, DiMeco F, Clatterbuck RE, Guarnieri M, Carson BS, Sr.: Experimental rodent models of brainstem tumors. Vet Pathol 39: 293-299, 2002
12. Kroin JS, Penn RD: Intracerebral chemotherapy: Chronic microinfusion of cisplatin. Neurosurgery 10: 349-354, 1982
13. Cartmill M, Punt J: Diffuse brain stem glioma. A review of stereotactic biopsies. Child's Nerv Syst 15: 235-238, 1999
14. Jackowski A: Brain stem surgery. Brit J Neurosurg 9: 581-584, 1995
15. Levesque MF, Parker F: MKM-guided resection of diffuse brainstem neoplasms. Oncology 73: 15-18, 1999
16. Steck J, Friedman WA: Stereotactic biopsy of brainstem mass lesions. Surg Neurol 43: 563-568, 1995
17. Xu QW, Bao WM, Mao RL, Jiang DJ, Yang GY: Surgical treatment of solid brain stem tumors in adults: a report of 22 cases. Surg Neurol 48: 30-36, 1997
18. Tamargo RJ, Myseros JS, Epstein JL, Yang MB, Chasin M, Brem H: Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Cancer Res 53: 329-333, 1993
19. Peterson K, Harsh G, Fisher PG, Adler J, Le Q: Daily low-dose carboplatin as a radiation sensitizer for newly diagnosed malignant glioma. J Neuro-Oncol 53: 27-32, 2001
20. Olivi A, Ewend MG, Utsuki T, Tyler B, Domb AJ, Brat DJ, Brem H: Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat. Cancer Chemother Pharmacol 39: 90-96, 1996
21. Friedman HS, Lovell S, Rasheed K, Friedman AH: Treatment of adults with progressive oligodendroglioma with carboplatin. Med Pediatr Oncology 31: 16-18, 1998
22. Dunkel IJ, Boyett JM, Yates A, Rosenblum M, Garvin JH, Bostrom BC, Goldman S, Sender LS, Gardner SL, Li H, Allen JC, Findlay JL, Children's Cancer Group: High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. J Clin Oncol 16: 222-228, 1998
23. Gruber ML, Glass J, Choudhri H, Nirenberg A: Carboplatin chemotherapy before irradiation in newly diagnosed glioblastoma multiforme. Am J Clin Oncol 21: 338-340, 1998
24. Bouffet E, Raquin M, Doz F, Gentet JC, Rodary C, Demeocq F, Chastagner P, Lutz P, Hartmann O, Kalifa C: Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer 88: 685-692, 2000
25. Morrison PF, Laske DW, Bobo H, Oldfield EH, Dedrick RL: High-flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol 266:R292-R305, 1994
26. Groothius DR, Ward S, Itskovich AC, Dobrescu C, Allen CV, Dills C, Levy RM: Comparison of 14C-sucrose delivery to the brain by intravenous, intraventricular, and convection-enhanced intracerebral infusion. J Neurosurg 90: 321-331, 1999
27. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci 91: 2076-2080, 1994
28. Chen MY, Lonser RR, Morrison PF, Governale LS, Oldfield EH: Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurgery 90: 315-320, 1999
29. Doz F, Berens ME, Dougherty DV, Rosenblum ML: Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures. J Neuro-Oncol 11: 27-35, 1991
30. Gietema JA, Meinardi MT, Messerchmidt J, Gelevert T, Alt F, Uges DRA, Sleifer DTh: Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer. Lancet 355: 1075-1076, 2000
31. Whittle IR, Malcolm G, Jodrell DI, Reid M: Plasma distribution in malignant glioma following intraoperative intravenous infusions of carboplatin. Brit J Neurosurg 13: 132-137, 2000
32. Shinohara C, Matsumoto K, Kuriyama M, Adachi H, Ono Y, Higashi H, Furuta T, Ohmoto T: Clinical pharmacokinetics of carboplatin and MCNU in malignant brain tumor and normal brain tissues [Japanese]. Jpn J Cancer Chemother 21: 1163-1168, 1994
33. Rand RW, Kreitman RJ, Patronas N, Varricchio F, Pastan I, Puri RJ: Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma. Clin Cancer Res 6: 2157-2165, 2000
34. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. Academic Press, Orlando, FL, 1986